In another study, Yan et al. showed that in cancer cells overexpressing HER2/neu, overtreatment with AMAD inhibited MAPK and PI3K/AKT-dependent signaling pathways, leading to growth inhibition and induction of apoptosis. The gene discussed is ERBB2; the disease is cancer.